NASDAQ · Drug Manufacturers - Specialty & Generic

Sonoma Pharmaceuticals, Inc. (SNOA) Stock

$1.23 +6.03% NASDAQ: SNOA Healthcare

Valuation

MetricValue
Price$1.23
Market Cap$5.89M
P/E Ratio-1.02
P/B Ratio0.72
P/S Ratio0.27
EPS (TTM)$-2.79
52-Week High$4.60
52-Week Low$0.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-53.56%
ROA-12.50%
ROCE-11.11%
Gross Margin-28.57%
Operating Margin-28.57%
Net Margin-10.33%
Debt/Equity0.11
Current Ratio3.25

Annual Financials (USD)

Metric20222023202420252026
Revenue$13.0M$13.0M$13.0M$14.0M$20.0M
Operating Profit$-6.0M$-5.0M$-5.0M$-4.0M$-2.0M
Net Profit$-5.0M$-5.0M$-5.0M$-3.0M$-3.0M
EPS$-19.17$-15.18$-5.32$-2.79$-1.89
Op Margin-46.6%-34.4%-36.9%-26.0%-12.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$19.0M$16.0M$15.0M$14.0M$14.0M
Total Liabilities$10.0M$8.0M$9.0M$9.0M$11.0M
Cash$7.0M$4.0M$3.0M$5.0M$2.0M
Borrowings$1.0M$1.0M$1.0M$0$1.0M

Latest News

Sonoma Pharmaceuticals Receives FDA Approval for Microdacyn's Expanded Indications, Packaging Options MT Newswires · Jun 30, 2026 Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution ACCESS Newswire · Jun 30, 2026 Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results ACCESS Newswire · Jun 16, 2026 Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering ACCESS Newswire · Apr 24, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-4.0M$-6.0M$-2.0M$0$-4.0M
Investing Cash Flow$0$-1.0M$0$0$0
Financing Cash Flow$0$1.0M$0$0$0
Net Cash Flow$3.0M$-4.0M$-1.0M$2.0M$-3.0M
Free Cash Flow$-4.0M$-6.0M$-2.0M$0$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.84
FCF Yield-36.24%
Quick Ratio2.29
Interest Coverage0.00
Return 1Y-66.85%
Return 3Y-94.70%
Return 5Y-99.01%

Ownership

Insiders Held0.42%
Institutions Held1.43%
Institutions Float Held1.43%
Institutional HolderSharesReport Date
Geode Capital Management, LLC19,9412026-03-31
Vanguard Capital Management LLC18,7872026-03-31
DRW Securities, LLC12,0152026-03-31
McKinley Carter Wealth Services, Inc.11,1932026-03-31
Morgan Stanley2,0042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BFRIBiofrontera Inc. $0.97 +5.57% -1.69 $12.42M 0.00%
CPHIChina Pharma Holdings, Inc. $0.87 -9.32% -0.65 $35.27M 0.00%
EVOKEvoke Pharma, Inc. $11.00 +0.00% -6.96 $18.95M 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
MYNZMainz Biomed B.V. $3.59 +0.84% -2.93 $14.69M 0.00%

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. is led by CEO Amy Trombly, employs 10 people, headquartered in US, publicly traded since 2007.

Sonoma Pharmaceuticals, Inc. (SNOA) stock trades at $1.23 with a market capitalization of $5.89M. The stock is valued at a price-to-earnings (P/E) ratio of -1.02, price-to-book of 0.72, price-to-sales of 0.27. Over the past 52 weeks the stock has ranged between $0.85 and $4.60, and currently trades 73.3% below its 52-week high.

On profitability, Sonoma Pharmaceuticals, Inc. generates a return on equity (ROE) of -53.56%, return on capital employed of -11.11%, an operating margin of -28.57%, a net profit margin of -10.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides